Author

Michelle Garcia

Oregon Health & Science UniversityPrimary ORCID profile (0009-0004-9927-4622 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Michelle GarciaiD1 paper · Dartmouth College

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:human· 1

Frequent Co-Authors

Fikadu TafesseiD· 2 shared Aidan AnastasiD· 1 shared Alec M. GriffithiD· 1 shared Ayna Alfahdli· 1 shared Eric BarklisiD· 1 shared Gaelen Donnelly Guzman· 1 shared John E. BurkeiD· 1 shared Jules B. WeinsteiniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Fikadu TafesseORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A critical signaling role for diacylglycerol in phagocytosis of M. tuberculosis

Alec M. Griffith, Michelle Garcia, Gaelen Donnelly Guzman, Fikadu Tafesse

This study identifies diacylglycerol (DAG) as critical for phagocytosis of M. tuberculosis, showing that DAG disruption reduces uptake without affecting receptor trafficking or cargo binding.

bioRxiv · Mar 23, 2026 · PreprintMicrobiology

Mapping SARS-CoV-2 Nucleocapsid Function with Nanobodies

Jules B. Weinstein, Timothy A. Bates, Aidan Anastas, Ayna Alfahdli, Mila Trank-Greene, Savannah K. McBride, Michelle Garcia, Matthew AH Parson, Meredith L. Jenkins, John E. Burke, Eric Barklis, Fikadu Tafesse

This study develops domain-specific nanobodies that inhibit SARS-CoV-2 infection by disrupting N protein phase separation and replication.

bioRxiv · Jan 27, 2026 · PreprintMicrobiology